Skip to content

HIV-positive women in clinical trials: A gap in the facts

START… and why the time is now

Treatment and PrEP could be on a ‘collision course’, warns resistance expert

What happens to people who become HIV positive in prevention trials?

Microbicides: the quest for user-friendly formulations

Fat loss caused by some anti-HIV drugs persists in the long term

New WHO treatment criteria could prevent 90% of vertical transmission

Lost funding means lost lives, says MSF

Adherence to ARV prevention methods is challenging, partly because they don’t treat illness